Innoviva, Inc. (INVA)
20.00
+0.25
(+1.27%)
USD |
NASDAQ |
Jan 30, 16:00
20.00
0.00 (0.00%)
After-Hours: 20:00
Innoviva EPS Diluted (Quarterly) : 1.082 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | 2.316 |
| Pfizer Inc. | 0.6197 |
| Bristol Myers Squibb Co. | 1.079 |
| Nektar Therapeutics | -1.875 |
| Oramed Pharmaceuticals, Inc. | 1.131 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 89.91M |
| Revenue (Quarterly) | 111.26M |
| Total Expenses (Quarterly) | 21.35M |
| Enterprise Value | 1.221B |
| Gross Profit Margin (Quarterly) | 67.87% |
| Profit Margin (Quarterly) | 80.81% |
| Earnings Yield | 6.97% |
| Operating Earnings Yield | 10.62% |
| Normalized Earnings Yield | 8.611 |